The problem is that the government is never transparent about what remedial measures it has taken to address complaints raised against pharma companies. Instead, it often obfuscates, deflects, or threatens academics who speak about the issue
The problem is that the government is never transparent about what remedial measures it has taken to address complaints raised against pharma companies. Instead, it often obfuscates, deflects, or threatens academics who speak about the issue